Literature DB >> 1948290

Rhinocerebral mucormycosis: a report of eleven cases.

P Chetchotisakd1, P Boonma, M Sookpranee, C Pairojkul.   

Abstract

Rhinocerebral mucormycosis (RCM) is a rare, fulminant fungal infection that usually occurs in diabetic or immunocompromised patients. The mortality rate has been reduced recently with the advent of amphotericin B combined with aggressive surgery. Eleven RCM patients have been treated over the past five years at Srinagarind Hospital. Eight had underlying diabetes, five had renal failure and three of them had both. In eight patients, the diagnosis was established by KOH preparation before histological confirmation. Only two cases revealed positive cultures for Rhizopus spp and Cunninghamella spp. All patients underwent surgical treatments (extensive debridement, 8 cases; sphenoidectomy, 7 cases; ethmoidectomy 8 cases; maxillectomy 5 cases and orbital exenteration, 6 cases). Amphotericin B was administered to all patients as soon as the diagnosis of RCM was made. Only three patients survived. Early diagnosis and cooperation among ophthalmologist, otolaryngologist and physician are the most important factors for the survival of patients with mucormycosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1948290

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Survival case of rhinocerebral and pulmonary mucormycosis due to Cunninghamella bertholletiae during chemotherapy for acute myeloid leukemia: a case report.

Authors:  Kei Yamamoto; Momoko Mawatari; Yoshihiro Fujiya; Satoshi Kutsuna; Nozomi Takeshita; Kayoko Hayakawa; Miki Nakamura; Yusuke Takanabe; Yutaka Maruoka; Masato Inoue; Tetsuo Hara; Satoshi Nagasaka; Niro Tayama; Yoshitsugu Miyazaki; Takashi Umeyama; Norio Ohmagari
Journal:  Infection       Date:  2020-07-27       Impact factor: 3.553

3.  Serious fungal infections in Thailand.

Authors:  M Chayakulkeeree; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-04       Impact factor: 3.267

4.  Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.

Authors:  Brad Spellberg; Yue Fu; John E Edwards; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 6.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

7.  Autopsy findings in diabetic patients: a 27-yr clinicopathologic study with emphasi on opportunistic infections and cancers.

Authors:  King-Yin Lam
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

8.  Successful treatment of invasive fungal rhinosinusitis caused by Cunninghamella: A case report and review of the literature.

Authors:  Yong-Cai Liu; Min-Li Zhou; Ke-Jia Cheng; Shui-Hong Zhou; Xue Wen; Cheng-Dong Chang
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.